therefore be dangerous. The inhaled form is generally safe in pregnancy. Budesonide chiefly acts as a glucocorticoid. Budesonide was initially patented in
sulfate), a short-acting beta2-adrenergic agonist, and budesonide, an inhaled corticosteroid. It is inhaled using a pressurized metered-dose inhaler. The most
Budesonide/glycopyrronium bromide/formoterol, sold under the brand name Breztri Aerosphere among others, is an inhalable fixed-dose combination medication
combination formulations budesonide/formoterol and mometasone/formoterol. In November 2005, the US Food and Drug Administration (FDA) released a health